94 related articles for article (PubMed ID: 35427205)
1. A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects.
Xu Z; Wang Y; Liu G; Chen J; Wang W; Cheng Y; Ren Q; Cui Y; Yang W; Liu Z; Chen X; Xue J; Chang T; Qu X; Yu S; Zhou Y; Xu K; Su Z; Deng Q; Zhao Y; Yang H
Expert Opin Investig Drugs; 2022 Jul; 31(7):737-746. PubMed ID: 35427205
[TBL] [Abstract][Full Text] [Related]
2. A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif
Liu G; Xue J; Wang Y; Liu Z; Li X; Qu D; Su Z; Xu K; Qu X; Qu Z; Sun L; Cao M; Wang Y; Chen X; Yu J; Liu L; Deng Q; Zhao Y; Zhang L; Yang H
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2585-2593. PubMed ID: 35771264
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions.
Ding Y; Chu N; Que L; Huang K; Chen Y; Qin W; Qian Z; Shi Y; Xu Z; He Q
Front Pharmacol; 2023; 14():1169103. PubMed ID: 37188262
[No Abstract] [Full Text] [Related]
4. Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X; Zhong G; Yao H; Wu J; Ye S
Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal
Hu C; Lin Q; Liu C; Liu J; Chen X; Li X; Zhao G; Zhang L
Cancer Chemother Pharmacol; 2020 Dec; 86(6):793-801. PubMed ID: 33089408
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of a new generic lurasidone: a phase I bioequivalence study in healthy Chinese subjects.
Liu Z; Xue J; Deng Q; Wang Y; Zhang L; Liu L; Xiao N; Chang T; Cui Y; Cheng Y; Liu G; Wang W; Zhou Y; Yang W; Qu X; Chen J; Zhao Y; Wang Z; Yang H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38643450
[TBL] [Abstract][Full Text] [Related]
10. Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trial.
Xu Z; Liu Z; Wang Y; Xue J; Chang T; Cui Y; Cheng Y; Liu G; Wang W; Zhou Y; Yu S; Ren Q; Yang W; Qu X; Chen J; Chen X; Deng Q; Yang H; Wang X
Expert Rev Clin Pharmacol; 2023 Apr; 16(4):363-370. PubMed ID: 36883362
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Bioequivalence of Rasagiline Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions: An Open, Randomized, Single-Dose, Double-Cycle, Two-Sequence, Crossover Trial.
Li Y; Qi L; Bai H; Liu Y; Fan R; Tu Y; Sun Y; Wang J; Qi Q; Feng X; Zhou D; Wang X
Front Pharmacol; 2020; 11():571747. PubMed ID: 33364947
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics and Bioequivalence of Cefprozil for Suspension and Granule Formulation in Healthy Chinese Volunteers: Two Single-Dose Crossover Studies.
Lin PP; Wang CJ; Liu YP; Li T; Gao XM; Ma YP; Shi P; Li X; Wang LX; Cao Y
Adv Ther; 2021 Feb; 38(2):1130-1142. PubMed ID: 33340343
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects.
Liu Z; Gao Z; Yang W; Zhang L; Xiao N; Qu D; Su Z; Xu K; Liu G; Wang Y; Ren Q; Yu S; Cheng Y; Zhou Y; Deng Q; Zhao Y; Wang Z; Yang H
Expert Opin Drug Metab Toxicol; 2022; 18(7-8):519-527. PubMed ID: 35961948
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioequivalence study of two ciprofloxacin hydrochloride tablets in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, two-formulation, two-sequence, two-period, single-dose crossover study.
Qin F; Wang GM; Huang JY; Wu JR; Song WJ; Deng J; Xiao Y; Wang JS; Zhu KW
Int J Clin Pharmacol Ther; 2021 Dec; 59(12):804-816. PubMed ID: 34503644
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, Bioequivalence, and Safety Studies of Pantoprazole Sodium Enteric-Coated Tablets in Healthy Subjects.
Chen Z; Gan F; Rao X; Huang X; Chen H
Clin Pharmacol Drug Dev; 2021 May; 10(5):502-509. PubMed ID: 33128847
[TBL] [Abstract][Full Text] [Related]
16. Effect of rifampicin on the pharmacokinetics of lenvatinib in healthy adults.
Shumaker RC; Aluri J; Fan J; Martinez G; Thompson GA; Ren M
Clin Drug Investig; 2014 Sep; 34(9):651-9. PubMed ID: 25022720
[TBL] [Abstract][Full Text] [Related]
17. A randomized, three-treatment, three-period, six-sequence-crossover, single-center, bioequivalence study to evaluate the impact of different 10-mg crystalline forms on the pharmacokinetics of lenvatinib in healthy volunteers.
Lee L; D'Angelo P; Verbel D; Martinez G; Aluri J; Brimhall D
Int J Clin Pharmacol Ther; 2015 Feb; 53(2):190-8. PubMed ID: 25600977
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
Li C; Xu J; Zheng Y; Chen G; Wang J; Ma L; Qiao Y; Niu J; Wu M; Zhang H; Li X; Chen H; Zhu X; Liu C; Ding Y
Chem Pharm Bull (Tokyo); 2017 Jun; 65(6):524-529. PubMed ID: 28392509
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the bioequivalence and safety of liraglutide injection
Liu C; Xu H; Yuan F; Chen H; Sheng L; Chen W; Xie H; Xu H; Li X
Front Pharmacol; 2023; 14():1326865. PubMed ID: 38186650
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects.
Wang Y; Xue J; Su Z; Cui Y; Liu G; Yang W; Liu Z; Chen J; Ren Q; Yu S; Cheng Y; Zhou Y; Wang W; Chen X; Qu D; Deng Q; Zhao Y; Yang H
Expert Opin Investig Drugs; 2023 Mar; 32(3):263-270. PubMed ID: 36757390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
